SafriCanna

Certification framework

Compliance is the product

In a regulated medicine, the buyer is not purchasing biomass. They are purchasing the certainty that a batch will pass their qualified person, their regulator and their auditor. Everything below is stated with its scope and its holder so that it can be verified rather than assumed.

EU-GMP
Part 1 certified
EudraLex
Listed site
GACP & CUMCS
Certified
Distribution
GDP compliant

Certifications and licences

EU-GMP Part 1

Manufacture of medicinal products

Holder: SafriCanna, Centurion site

Certification against Part 1 of the EU Guidelines to Good Manufacturing Practice for medicinal products for human use — the standard applied to finished medicines, not to agricultural produce.

EudraLex listing

Manufacturing site listing

Holder: Centurion site

The site is listed as a manufacturing site in the European regulatory framework, which is what allows an EU importer's qualified person to rely on it in their own release decision.

SAHPRA licences

Cultivation, manufacture, export

Holder: SafriCanna

Licensing by the South African Health Products Regulatory Authority under the Medicines and Related Substances Act, maintained in good standing with periodic inspection.

GACP

Good Agricultural and Collection Practice

Holder: Cultivation operation

Applies documented control to the growing phase — seed and plant provenance, inputs, water, personnel hygiene and harvest handling — so that the active raw material entering GMP manufacture is itself controlled.

CUMCS

Certification for medical cannabis

Holder: SafriCanna

Sector-specific certification covering cultivation and processing of cannabis for medical use, aligned to GACP and GMP expectations.

GDP

Good Distribution Practice

Holder: Outbound logistics

Applied to storage and transport so that temperature, security and chain of custody are maintained and documented from release to the receiving licence holder.

Current certificates, licence numbers and inspection dates are provided to licensed counterparties on request through the enquiry channel. They are not published, because certificate scope changes and a stale published copy is a compliance risk in itself.

Quality governance

The system that makes the certificate mean something

Independent quality unit
Quality is structurally independent of production and holds sole release authority.
Qualified-person review
Every batch record is reviewed and dispositioned before dispatch.
Controlled documentation
Versioned procedures, records and specifications under formal document control.
Deviation and CAPA
Deviations are logged, investigated, and closed with corrective and preventive action.
Change control
No validated process, area, system or supplier changes without assessed, approved change control.
Supplier qualification
Inputs and service providers are qualified and periodically re-assessed.
Self-inspection
A scheduled internal audit programme tests the system between external inspections.
Audit readiness
Documentation is maintained for regulator, customer and change-of-control audit at any time.

How we are allowed to communicate

Marketing guardrails applied to this website

Medical cannabis is a prescription medicine in every market SafriCanna supplies, so the rules that govern pharmaceutical promotion govern this site. These are the guardrails applied to every page, and to any material produced by an agency on SafriCanna's behalf.

  • No promotion of a prescription medicine to the general public (South African Medicines Act and SAHPRA requirements; EU Directive 2001/83/EC, Article 88).
  • No therapeutic, efficacy or safety claims, no named indications, no patient outcomes and no testimonials.
  • No cultivar names, potency figures, THC or CBD percentages, or chemotype data on public pages.
  • No product, flower, oil, packaging, consumption or lifestyle imagery.
  • No pricing, availability or ordering mechanics; commercial contact is an enquiry channel for licensed entities.
  • Technical product information is released only to persons who declare a licensed or professional capacity.
  • Every certification claim states its scope and holder, and must be substantiated by a current certificate.
  • No comparative or disparaging claims about other producers, countries or products.

This summary is an operating standard, not legal advice. Market-specific requirements differ, and local counsel should review any market-facing material before publication in that market.

Compliance notice

This website is corporate and manufacturing information intended for licensed businesses, healthcare professionals and prospective counterparties. It is not promotional material for a medicine, it is not directed at patients or the general public, and nothing on it constitutes medical advice or an offer to supply.

Medical cannabis is a prescription medicine. SafriCanna does not make therapeutic, efficacy or safety claims, does not name indications, and does not supply the public. Any product may only be obtained through a licensed distribution channel on the authorisation of a healthcare professional in the patient's jurisdiction.

Read the full compliance notice